KLCMU
BMY.RT

Kite Lake Capital Management (UK)’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Kite Lake Capital Management (UK)’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,472,340
Closed -$1.02M – 7
2020
Q4 		$1.02M Hold
1,472,340
– – 0.84% 5
2020
Q3 		$3.31M Hold
1,472,340
– – 3.31% 6
2020
Q2 		$5.27M Hold
1,472,340
– – 8.2% 4
2020
Q1 		$5.59M Buy
1,472,340
+1,030,000
+233% +$3.39M 8.93% 4
2019
Q4 		$1.33M Buy
+442,340
New +$1.15M 4.22% 3

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Kite Lake Capital Management (UK)'s BMY.RT Position: Q1 2021 in Review

Kite Lake Capital Management (UK) sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 1,472,340 shares — an estimated $1.02M sold.

Kite Lake Capital Management (UK) first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $5.59M in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Kite Lake Capital Management (UK) reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Kite Lake Capital Management (UK) sold 1,472,340 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $1.02M.
  • Kite Lake Capital Management (UK) first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Kite Lake Capital Management (UK)'s Bristol-Myers Squibb Company Contingent Value Rights position peaked at $5.59M in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Kite Lake Capital Management (UK)'s 13F filing for Q1 2021, filed 17 May 2021.